New Key Statistics Module, Z-Score and F-Score
NAS:IBRX Key Ratios
Market Cap $ M | 6,194.88 |
Enterprise Value $ M | 6,519.74 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 9,195.56 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -1.16 |
Beneish M-Score | -2.5 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -14.34 |
EV-to-EBITDA | -14.95 |
PEG | -- |
Shares Outstanding M | 677.04 |
Net Margin (%) | -93,761.42 |
Operating Margin % | -58,097.11 |
Pre-tax Margin (%) | -93,873.31 |
Quick Ratio | 5.05 |
Current Ratio | 5.05 |
ROA % (ttm) | -150.79 |
ROE % (ttm) | -- |
ROIC % (ttm) | -68.26 |
Dividend Yield % | -- |
Altman Z-Score | -7.30 |
IBRX Number of Guru Trades
IBRX Volume of Guru Trades
Gurus Latest Trades with NAS:IBRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IBRX is held by these investors
Total 1
ImmunityBio Inc Insider Transactions
No Available Data
News about NAS:IBRX
Total 0- 1